Pharma Cold Chain Logistics in India: Planning Temperature-Controlled Shipments

Pharma cold chain logistics protects temperature-sensitive pharmaceutical products while they move between manufacturers, depots, laboratories, hospitals and other authorised recipients. A dependable plan does more than provide a refrigerated vehicle. It establishes the product’s approved transport conditions, qualified packaging or equipment, continuous monitoring, controlled handovers, documented responsibilities and a response process for any temperature excursion.

The correct temperature range is product-specific. It must come from approved product information, stability data and the shipper’s quality requirements. A general article cannot decide whether a medicine, vaccine, biological product or diagnostic material remains suitable after an excursion. That assessment belongs to the authorised quality team.

What makes pharmaceutical cold-chain transport different?

Ordinary transport planning focuses on origin, destination, weight, volume, pickup time and delivery requirement. A temperature-controlled pharmaceutical movement adds another layer: the product must remain within defined environmental conditions throughout packing, staging, loading, movement, transfer, unloading and delivery.

WHO guidance for time- and temperature-sensitive pharmaceutical products treats the cold chain as a controlled system. The CDSCO draft guidance on good distribution practices for pharmaceutical products also addresses suitable storage and transport conditions, documentation, training, complaints, returns and recalls. Businesses should apply the requirements relevant to their product, licence, contract and applicable law rather than treating any guidance summary as legal advice.

Start with a shipment qualification brief

Before requesting a quotation, the shipper should provide enough information for the logistics team to assess whether the movement can be performed under the required conditions. The brief should cover:

• Exact product category and approved commodity description
• Required transport temperature range and permitted exposure conditions
• Number of packages, dimensions, weight and total volume
• Packaging system and its qualified duration
• Origin, destination, pickup readiness and delivery window
• Route duration, planned transfers and contingency allowance
• Data-logger quantity, placement, reading interval and retrieval method
• Loading, unloading and maximum door-opening requirements
• Documentation, security, handling and authorised-recipient requirements
• Escalation contacts and the person authorised to decide product disposition

TCI EXPRESS places particular emphasis on sanitisation before and after loading and unloading, planned equipment maintenance and cooling-performance checks. Because pharmaceutical cargo is sensitive, the team reviews applicable regulatory controls and shipment documentation before movement. Requirements that need technical evaluation are taken through defined operating procedures and protocols agreed with the customer. Final acceptance remains subject to the product, temperature condition, packaging or equipment, route, available capacity and applicable commercial approval.

Packaging and vehicles perform different jobs

An active refrigerated vehicle controls the environment inside its cargo space. A qualified passive package uses insulation and conditioned refrigerants to protect its contents for a defined period. Some movements use both. Neither approach should be selected by habit: the product, shipment size, route, ambient exposure, handling plan and contingency time determine the suitable system.

Pre-cooling a vehicle does not automatically condition the product or packaging. Similarly, placing extra refrigerant inside a box can create a freezing risk if the pack-out has not been qualified. Loading patterns also matter because blocked airflow, prolonged door opening or unplanned staging can create temperature differences within the load.

How should temperature monitoring be planned?

Monitoring should produce usable evidence, not simply a live number on a screen. The shipment plan should define which devices are used, where they are placed, how often they record, who receives alerts, what threshold triggers action and how the record is retained.

TCI EXPRESS reports that its pharmaceutical logistics operation supports temperature-sensitive movements with continuous temperature and location monitoring. Its FY 2024–25 disclosures describe real-time tracking, GPS visibility, data loggers, pre-cooling to minus 18 degrees Celsius for the cited frozen-product process, additional checks near doors, pull-down and holding tests, and air-leakage inspections. These are service-level examples, not a universal temperature specification for every pharmaceutical product.

Each approved movement follows standard operating procedures together with customer-specific agreed protocols. Temperature is monitored through advanced automated systems during the journey, with location and temperature information reviewed against the agreed conditions. The monitoring and escalation configuration depends on the shipment and technical agreement. Alert thresholds, customer visibility, reporting intervals and the final temperature-record format should therefore be documented before dispatch.

Control every handover, not only the line-haul journey

Temperature exposure can occur while a shipment waits for pickup, moves between controlled and uncontrolled areas, is checked at a gate, changes vehicles or waits for an authorised recipient. A practical route plan therefore identifies each custody transfer and the maximum planned time outside the controlled environment.

Useful controls include:

• Confirmed pickup readiness before the vehicle reaches the site
• Documented vehicle or packaging pre-conditioning
• Seal, package-count and condition checks at dispatch
• Named responsibility at each transfer point
• Minimal and controlled door-opening time
• Live location and temperature review during movement
• Recipient availability before arrival
• Delivery acknowledgement and retrieval of monitoring records

What happens when a temperature excursion occurs?

A temperature excursion is a recorded condition outside the agreed transport range or another approved limit. It does not automatically prove that a product is unusable, and it must not be dismissed merely because the shipment looks normal.

The transport team should preserve the shipment, record the event, protect the data and notify the authorised contacts. The shipper’s quality team can then review the duration and extent of the excursion against product-specific stability information and decide whether the product may be released, quarantined, returned or rejected.

• Do not alter or discard logger data
• Record location, time, observed temperature and shipment condition
• Keep the product under the instructed controlled condition
• Notify the agreed logistics and quality contacts
• Document corrective action and custody changes
• Do not make a product-quality decision without authorised review

TCI EXPRESS plans alternate handling options for special cases and coordinates them through its central rapid-response team. When a temperature deviation, vehicle problem, route disruption or delivery obstacle is detected, the immediate priorities are to protect the controlled condition, notify the designated contacts and assess the safest available contingency. The central team synchronises the operational response with the relevant local or zonal teams and keeps the customer informed until delivery or another authorised disposition is completed. Event records, monitoring data and corrective actions are retained for review under the applicable protocol.

How should a business evaluate a pharma cold-chain partner?

A provider should be assessed against the shipment’s actual risk profile. Ask for evidence that the proposed equipment, process and route fit the product requirement.

• Can the provider confirm the lane and required temperature condition?
• How are vehicles, containers or passive packaging qualified?
• What calibration and maintenance records are available?
• How are staff trained for loading, monitoring and exception response?
• Which temperature and location milestones can customers see?
• How is backup capacity arranged for equipment or route failure?
• How are cleaning, sanitation, security and cross-contamination risks managed?
• What records are supplied after delivery?
• Who decides product disposition after an excursion?
• What liability, insurance and claims conditions apply?

Customers can submit a business enquiry with the product and lane requirements. General network availability can be checked through the pincode enquiry, but cold-chain acceptance still requires shipment-specific confirmation.

A practical pre-dispatch checklist

• Product transport condition confirmed by the authorised quality team
• Lane, vehicle or packaging system and contingency time approved
• Package configuration and logger placement documented
• Vehicle or packaging pre-conditioning completed
• Documents, labels, seals and contact details verified
• Pickup and delivery sites ready to prevent avoidable waiting
• Alert thresholds and escalation contacts tested
• Excursion-response and product-disposition responsibilities agreed
• Delivery evidence and temperature-record format confirmed

Final takeaway

Reliable pharma cold chain logistics is built before dispatch. The product requirement must guide the packaging, equipment, route, monitoring and response plan. Continuous visibility is valuable only when trained people know what action to take and an authorised quality team controls product decisions.

TCI EXPRESS can evaluate temperature-controlled pharmaceutical requirements through its specialised service team. Customers should provide the complete shipment profile and obtain written confirmation of serviceability, operating conditions and commercial terms before booking.